Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122820205 | 12282020 | 5 | F | 20160331 | 20160627 | 20160419 | 20160712 | PER | US-ACTELION PHARMACEUTICALS US, INC.-A-US2016-134501 | ACTELION | 41.00 | YR | A | F | Y | 0.00000 | 20160712 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122820205 | 12282020 | 1 | PS | OPSUMIT | MACITENTAN | 1 | Oral | 10 MG, QD | UM016A0201 | 204410 | 10 | MG | TABLET | QD | |||||
| 122820205 | 12282020 | 2 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 1400 MCG, BID | 0310244 | 207947 | 1400 | UG | TABLET | BID | |||||
| 122820205 | 12282020 | 3 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 1200 MCG, UNK | 207947 | 1200 | UG | TABLET | |||||||
| 122820205 | 12282020 | 4 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 800 MCG, BID | 30951801 | 207947 | 800 | UG | TABLET | BID | |||||
| 122820205 | 12282020 | 5 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 600 MCG, UNK | 30951801 | 207947 | 600 | UG | TABLET | ||||||
| 122820205 | 12282020 | 6 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 200 MCG, UNK | 207947 | 200 | UG | TABLET | |||||||
| 122820205 | 12282020 | 7 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 1200 MCG, BID | 0310253 | 207947 | 1200 | UG | TABLET | BID | |||||
| 122820205 | 12282020 | 8 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 2.5 MCG, 3-9X/DAY | MA025AV | 21779 | 2.5 | UG | INHALATION VAPOUR, SOLUTION | ||||||
| 122820205 | 12282020 | 9 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 5 MCG, 6-9 X/DAY | MA025AV | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION | ||||||
| 122820205 | 12282020 | 10 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 5 MCG, 3-9 X/DAILY | MA025AV | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION | ||||||
| 122820205 | 12282020 | 11 | C | SILDENAFIL. | SILDENAFIL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122820205 | 12282020 | 1 | Pulmonary arterial hypertension |
| 122820205 | 12282020 | 2 | Pulmonary arterial hypertension |
| 122820205 | 12282020 | 8 | Pulmonary arterial hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122820205 | 12282020 | Arthralgia | |
| 122820205 | 12282020 | Fatigue | |
| 122820205 | 12282020 | Feeling abnormal | |
| 122820205 | 12282020 | Feeling hot | |
| 122820205 | 12282020 | Flushing | |
| 122820205 | 12282020 | Headache | |
| 122820205 | 12282020 | Insomnia | |
| 122820205 | 12282020 | Malaise | |
| 122820205 | 12282020 | Migraine | |
| 122820205 | 12282020 | Myalgia | |
| 122820205 | 12282020 | Nausea | |
| 122820205 | 12282020 | Pain | |
| 122820205 | 12282020 | Pain in jaw |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122820205 | 12282020 | 1 | 20140109 | 0 | ||
| 122820205 | 12282020 | 4 | 20160331 | 0 | ||
| 122820205 | 12282020 | 5 | 201603 | 20160331 | 0 | |
| 122820205 | 12282020 | 6 | 20160308 | 201603 | 0 | |
| 122820205 | 12282020 | 8 | 20130913 | 0 |